Antimycotic systems of bifidobacteria
Department of Medical Biotechnology, G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology, Russia 125212, Moscow, Admiral Makarov Street, 10.
Review Article
World Journal of Advanced Research and Reviews, 2021, 09(01), 069-074
Article DOI: 10.30574/wjarr.2021.9.1.0496
Publication history:
Received on 22 December 2020; revised on 02 January 2021; accepted on 04 January 2021
Abstract:
Based on own data, the basis positions concerning probiotic bifidobacteria as producers of adaptable and controlled network of functionally coupled antimycotics of the recognition type (lectin and lectin-like type) were described. Such antimycotics act as an organized ordered system of metabolomebiotics which are distinct from the classical antibiotics, acting with other (expanded) mechanisms resulting in increase of resistance of the organism protective network. Bifidobacterial antimycotics are represented by probiotc lectin and postbiotic systems of promised prophylactic and therapeutic significance in future.
Keywords:
Bifidobacteria; Probiotics; Postbiotics; Antimycotics; Lectin systems; Glycoconjugates
Full text article in PDF:
Copyright information:
Copyright © 2021 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0